Try our beta test site
82 studies found for:    Open Studies | "Salivary Gland Diseases"
Show Display Options
Rank Status Study
21 Recruiting SPI-directed Analgesia for Vitreoretinal Surgeries
Conditions: Vitreoretinal Surgeries;   Postoperative Nausea and Vomiting;   Postoperative; Parotitis
Interventions: Drug: Metamizol;   Drug: Acetaminophen;   Drug: 0,5 % bupivacaine with of 2% lidocaine;   Drug: Proxymetacaine
22 Not yet recruiting Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use
Conditions: Overactive Bladder;   Xerostomia;   Compliance
Intervention: Drug: Biotene oral spray
23 Recruiting The ASSESS National Multi-center Prospective Cohort
Condition: Primary Sjögren's Syndrome
Intervention: Other: No intervention
24 Recruiting Study of Iguratimod in Sjögren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Iguratimod
25 Not yet recruiting Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Condition: Primary Sjögren's Syndrome
Intervention: Other: Blood samples
26 Recruiting Ultrasound Elastography of Salivary Glands
Condition: sjögren Disease
Intervention:
27 Not yet recruiting Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
Condition: Primary Sjogren's Syndrome
Interventions: Biological: VAY736;   Other: Placebo
28 Recruiting Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor
Conditions: Sjogren's Syndrome;   Neonatal Systemic Lupus Erythematosus;   Fetal Heart Block Complete
Intervention:
29 Recruiting A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
Condition: Sjogrens Disease
Interventions: Biological: Abatacept;   Other: Placebo
30 Recruiting A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts
Condition: Autoimmune Diseases
Interventions: Radiation: 18F-FDG PET/CT Imaging;   Radiation: 11C-MET PET/CT Imaging;   Procedure: MRI Imaging with intravenous contrast with gadoterate meglumine;   Procedure: Minor Salivary gland (labial) biopsy
31 Recruiting Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine
Conditions: Encephalitis, Japanese;   Measles;   Mumps;   Rubella
Interventions: Biological: CD-JEV;   Biological: MMR
32 Recruiting Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers
Condition: Salivary Glands Tumors
Intervention: Drug: Abiraterone acetate
33 Recruiting Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14
Condition: Adenoid Cystic Carcinomas of the Salivary Glands
Intervention: Drug: Lenvatinib
34 Recruiting Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14
Condition: Salivary Gland Cancers
Intervention: Drug: Axitinib
35 Recruiting Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
36 Recruiting Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: BMS-931699;   Drug: BMS-986142;   Drug: Placebo
37 Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
38 Not yet recruiting Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CDZ173;   Drug: Placebo
39 Recruiting Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome
Conditions: Sjögren Syndrome;   Pulmonary Hypertension
Intervention:
40 Recruiting A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Matching Placebo;   Drug: RO5459072

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.